Preparative and Process Chromatography Market Summary
As per Market Research Future Analysis, the Global Preparative and Process Chromatography Market was valued at USD 7.42 billion in 2024 and is projected to reach USD 14.13 billion by 2035, growing at a CAGR of 6.03% from 2025 to 2035. The market is driven by the increasing demand for monoclonal antibodies in the pharmaceutical and biotechnology sectors, as well as the rising prevalence of diabetes, which necessitates efficient insulin production. Recent innovations, such as Tecan's Resolvex Prep, are enhancing sample preparation efficiency, further supporting market growth.
Key Market Trends & Highlights
Key trends influencing the market include technological advancements and rising healthcare demands.
- The prevalence of diabetes is expected to reach 700 million globally by 2045, increasing insulin demand by over 20%.
- Monoclonal antibodies are crucial for cancer treatment, with cancer accounting for 1 in 6 deaths worldwide.
- Preparative chromatography dominates the market due to its role in providing pure molecules for pharmaceuticals.
- Liquid chromatography is the leading segment, driven by its extensive application across various industries.
Market Size & Forecast
2024 Market Size | USD 7.42 Billion |
2035 Market Size | USD 14.13 Billion |
CAGR (2024-2035) | 6.03% |
Major Players
Major players include Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Thermo Fisher Scientific, Shimadzu Corporation, Daicel Corporation, Waters Corporation, Agilent Technologies, Novasep Holding S.A.S., and PerkinElmer Inc.